Lessons from the Trenches: Trial Tactics Defending COVID 19 and Genetic Testing Cases

The government alleged a 65-million-dollar kickback and healthcare fraud conspiracy against owners of a laboratory which specialized in COVID-19 and pharmacogenomic testing. Host Ramana Rameswaran speaks to Andrew Feldman, of the Feldman Firm, to discuss the impact of this case, why this case and the trial may affect the theories the government utilizes in future indictments and FCA enforcement actions, and how the government might develop future COVID-19 cases.